6
Views
0
CrossRef citations to date
0
Altmetric
Literature Alerts

Literature Alerts

Pages 723-734 | Published online: 27 Sep 2008

LITERATURE ALERTS

  • Preparation and evaluation of zidovudine-loaded sustained-release microspheres: 2. Optimi-zation of multiple response variables. ABU, I. K., GARCIA, C. L., and Lu, D. R., J. Pharm. Sci., 1996, 85 (6), 572–576.
  • Chitosan microspheres of diclofenac sodium: I. Application of factorial design and evaluation of release kinetics. ACIKGOEZ, NI., KAS, H. S., ORMAN, M., and HINCAL, A. A., J. Microencapsu-lation, 1996, 13 (2), 141–159.
  • Allogeneic human liposomal melanoma vaccine with or without IL-2 in metastatic melanoma patients: clinical and immunobiological effects. ADLER, A., SCHACHTER, J., BARENHOLZ, Y., BAR, L. K., KLEIN, T., KORYTNAYA, R., SULKES, A., MicHowerz, R., COHEN, Y., and KEDAR, I., Cancer-Biother, 1995, 10 (4), 293–306.
  • Determination of NO by using liposome PTIO. AKAIKE, T., Kekkan to Naihi, 1996, 6 (Suppl), 92–97.
  • %5-Fluorouracil-loaded chitosan microspheres: preparation and release characteristics. AKBUGA, J., and BERGISADI, N., J. Microencapsulation, 1996, 13 (2), 161–168.
  • Studies on the formulation and in vitro release of ophthalmic liposomes containing dexa-methasone sodium phosphate. AL MUHAMMAD, J., OEZER, A. Y., and HINCAL, A. A., J. Microencapsulation, 1996, 13 (2), 123–130.
  • Heparin protection against Fe2 + - and Cu2 + -mediated oxidation of liposomes. ALBERTINI, R., RIND, S., PASS, A., PALLAVICINI, G., and DE LUCA, G., FEBS Lett., 1996, 383 (3), 155–185.
  • The effect of cornea proteoglycans on liposome peroxidation. ALBERTINI, R., RIND, S., PASS, A., BARDONI, A., SALVINI, R., PALLAVICINI, G., and DE LUCA, G., Arch. Biochem. Biophys., 1996, 327 (2), 209–214.
  • Development of inherently echogenic liposomes as an ultrasonic contrast agent. ALKAN, 0. H., DEMOS, S. M., LANZA, G. M., VONESH, M. J., KLEGERMAN, M. E., KANE, B. J., KUSZAK, J., and McPeeesoN, D. D., J. Pharm. Sci., 1996, 85 (5), 486–490.
  • Immunization with cholesterol-rich liposomes induces anti-cholesterol antibodies and reduces diet-induced hypercholesterolemia and plaque formation. ALVIN, C. R., SWARTZ, G. M. JR, WASSEF, N. M., RIBAS, J. L., HERDERICK, E. E., VIRMANI, R., KOLODGIE, F. D., IVIATv As, G. R., and CORNHILL, J. F., J. Lab. Clin. Med., 1996, 127 (1), 40–49.
  • Basic experiment of BBB permeability of cisplatin encapsulated in liposome by means of in vitro BBR model with bovine brain microvessel endothelial cells. ANDA, T., YANIASH ITA, H., FUJITA, H., TOKUNAGA, Y., and SHIBATA, S., Drug Delivery Syst., 1995, 10(6), 425–430.
  • Free amino group content of serum albumin microcapsules. III. A study at low pH values. ANDRY, M. C., EDWARDS, L. F., and LEVY, M. C., Int. y. Pharm., 1996, 128 (1, 2), 197–202.
  • Influence of phospholipid chain length on verotoxin/globotriaosyl ceramide binding in model membranes: comparison of a supported bilayer film and liposomes. ARAB, S., and LINGWOOD, C. A., Glycoconjugate y., 1996, 13 (2), 159–166.
  • Inhibitory effects of negatively charged liposomes on nitric oxide production from macro-phages stimulated by LPS. ARAMAKI, Y., NITTA, F., MATSUNO, R., MORIMURA, Y., and TSUCHIYA, S., Biochem. Biophys. Res. Commun., 1996, 220 (1), 1–6.
  • Liposomes: carrier system in food products. ARNAUD, J. P., Int. Food Ingredients, 1995, (5), 29-32. Liposomes in the agro/food industry. ARNAUD, J. P., Agro. Food. Ind. Hi. Tech., 1995, 6 (5), 30-36. Specific targeting of phototoxic haptenated liposomes to a hapten-specific B cell lymphoma. AvRILioNis, vRILioNis., and Boucs, J. M., Cell Immunol., 1996, 168 (1), 13–23.
  • Priming for virus-specific CD8 + but not CD4 + cytotoxic T lymphocytes with synthetic lipopeptide is influenced by acylation units and liposome encapsulation. BABU, J. S., NAIR, S., KANDA, P., and Rouse, B. Y., Vaccine, 1995, 13 (17), 1669–1676.
  • Production of oil-containing crosslinked poly(vinyl alcohol) microcapsules by phase separa-tion: effect of process parameters on the capsule size distribution. BACHTSI, A. R., BOUTRIS, C. J., and KIPARISSIDES, C., y. Appl. Polym. Sci., 1996, 60 (1), 9–20.
  • Albumin-heparin microspheres as a drug delivery carrier. BAE, Y. H., KWON, G., CRENIERS, H., KIM, S. W., and FEIJEN, J., Yakche Hakhoechi, 1995, 25 (3, Suppl.), S21–S32.
  • Vidarabine liposomes: preliminary studies on the encapsulation of formulations. BARBOSA, C. M., and DA CRUZ, E. M. E. M., Rev. Port. Farm., 1995, 45 (4), 161–173.
  • Placental transfer of valproic acid after liposome encapsulation during in vitro human 0025-2048/96 $12.00 CO 1996 Taylor Sz Francis Ltd. placenta perfusion. BARZAGO, NI. NI., BORTOLOTTI, A., STELLAR', F. F., DIOMEDE, L., ALGERI, EFRATt, FRATt., SALNIONA, NI., and BONATI,Pharmacol. Exp. Ther., 1996, 277 (1), 79–86.
  • Pore formation by S. aureus a-toxin in liposomes and planar lipid bilayers: effects of nonelectrolytes. BASHFORD, C. L., ALDER, G. NI., FULFORD, L. G., KORCHEV, Y. E., KOVACS, E., NIAcKINNox, A., PEDERZOLLI, C., and PASTERNAK, C. A., y. Membr. Biol., 1996, 150 (1), 37–45.
  • Eradication of mucoid Pseudomonas aeruginosa with fluid liposome-encapsulated tobra-mycin in an animal model of chronic pulmonary infection. BEAULAC, C., CLEMENT, M. S., HAWARI, J., and LAGACE, J., Antimicrob. Agents Chemother., 1996, 40 (3), 665–669.
  • Thermodynamics of partitioning of nonsteroidal anti-inflammatory drugs in the n-octanol/ buffer and liposome systems. BETAGERI, G. V., NAYERNANIA, A., and HABIB, M. J., int. J. Pharm. Adv., 1996, 1(3), 310–319.
  • Preclinical and clinical activity of liposomal doxorubicin. BOMAN, N. L., Gews, P. R., BALLY, NI. B., and MAYER, L. D., Drug Targeting Delivery, 1995, 6, 85–103.
  • Vincristine-induced dermal toxicity is significantly reduced when the drug is given in liposomes. BONIAN, N. L., TRON, V. A., BALLY, NI. B., and CULLIS, P. R., Cancer Chemother. Pharmacol., 1996, 37 (4), 351–355.
  • Physical and chemical stabilities of Liposomes. BOZKIR, A., and KocYIGIT, S., Ankara Univ. Eczacilik, Fak. Derg., 1995, 24(1), 42–52.
  • Effect of donor strains and age of the recipient in the use of microencapsulated hepatocytes to control hyperbilirubinemia in the Gunn rat. BRuN:, S., and CHANG, T. NI., Int. J. Artif. Organs, 1995, 18 (6), 332–339.
  • Semipermeable alginate-PLO microcapsules as a bioartificial pancreas. BUGARSKI, B., DAVINIC, V., SAJC, L., GOOSEN, M., JOVANOVIC, G., VUNJAK, N. G., and DORDEVIC, P., Chem. Ind. (Belgrade), 1995, 49(12), 531–534.
  • Plasmid-liposome transfer of the alpha 1 antitrypsin gene to cystic fibrosis bronchial epithelial cells prevents elastase-induced cell detachment and cytokine release.
  • CANONIC°, A. E., BRIGHANI, K. L., CARNIICHAEL, L. C., PUTMAN, J. D., KING, G. A., BLACKWELL, T. R., and CHRISTNIAN, J. W., Am. y. Respir. Cell. Mol. Biol., 1996, 14(4), 348–355.
  • Effect of a single infusion of recombinant human proapolipoprotein A- I liposomes (synthetic HDL) on plasma lipoproteins in patients with low high density lipoprotein cholesterol. CARLSON, L. A., Nutr. Metab. Cardiovasc. Dis., 1995, 5 (2), 85–91.
  • Receptor ligand-facilitated gene transfer: enhancement of liposome-mediated gene transfer and expression by transferrin. CHENG, P. NV., Hum. Gene. Ther., 1996, 7 (3), 275–282.
  • Double emulsion microencapsulation of proteins as model antigens using polylactide polymers. Effect of emulsifier on the microsphere characteristics and release kinetics. CoNwAY, B., and ALPAR, H. 0., Eur. y. Pharm. Biopharm., 1996, 42(1), 42–48.
  • In vitro characteristics of nicotine microspheres for transnasal delivery. CORNAZ, A. L., ASCENTIS, A. DE, COLOMBO, P., and BURI, P., Int. J. Pharm., 1996, 129 (1, 2), 175–183.
  • Preparation of controlled releasing acrylic polymer microspheres of acebutolol hydrochloride and those powder-coated microspheres with sodium alginate in a polymeric spherical crystallization system. Cul, F., K.AWASHIMA, Y., TAKEUCHI, H., NIWA, T., and HINO, T., Chem. Pharm. Bull., 1996, 44 (4), 837–842.
  • Pesticide and model drug release from carboxymethylcellulose microspheres. DARARI, R., and HASIRICI, C., J. Microencapsulation, 1996, 13 (1), 9–24.
  • Protective immunity induced by liposome-supplemented influenza virus subunit antigen administered intranasally to mice. DE HAAN, A., VAN SCHARRENBURG, G. J. M., NIAsn-u, K. N., BENDER, B. S., SMALL, P. A. ja., and WILSCHUT, J., Vaccine Res., 1995, 4 (4), 207–216.
  • Liposomes and antiviral mucosal immunity. DE HANN, A., and WILSCHUT, J., Drug Targeting Delivery, 1995, 6, 69–83.
  • Calculation of van't Hoff enthalpy associated with aspirin-induced change in liposomal membrane anisotropy. DE, S., GOSH, A. K., BAsu, R., and NANDY, P., Phys. Med. Biol., 1996, 41(3), 383–386.
  • Microencapsulated permethrin sprays for control of Southern cattle tick, Boophilus microplus (Canestrini) (Acari:Ixodidae), infesting Holstein dairy heifers on Sant Croix, U.S. Virgin Islands. DESPINS, J. L., HUNTER, J. S. III, DAVEY, R. B., and GEORGE, J. E., J. Agric. Univ. P.R., 1995, 79 (3-4), 93–98.
  • Characteristics of microencapsulated palm-based oil as affected by type of wall material. DIAN, N. L. H. NI., SUDIN, N., and YUSOFF, NI. S. A., y. Sci. Food Agric., 1996, 70(4), 422–426.
  • Reversible adsorption of endopectin-Iyase to tailor-made core-shell microspheres prepared by dispersion polymerization. 3. DINELLA, C., DORIA, NI., LAUS, M., and LANZARINI, G., Biotechnol. Appl. Biochem., 1996, 23 (2), 133–140.
  • Effectiveness of liposomal forms of cytostatics. DRANIOV, A. L., DUDNICHENKO, A. S., NIAzIN, I. A., MENZELEEV, R. F., KRASNOPOL,Y. NI., and SHVETS, V. I., Byull. Eksp. Biol. Med., 1996, 121 (1), 85–88.
  • Assembly of Fe203 nanoparticles with polymer microspheres by encapsulated copolymeriza- tion. Du, H., KAN, S., ZHANG, G., Liu, F., TANG, X., and Li, T., Gaodeng Xuexiao Huaxue Xuebao, 1995, 16(11, Suppl.), 33–36.
  • The influence of lipid composition and lamellarity of liposomes on the physical stability of liposomes upon storage. DU PLESSIS, J., RANIACHANDRAN, C., WEINER, N., and MULLER, D. G., Int. J. Pharm., 1996, 127 (2), 273–278.
  • Characterization of enzyme immobilization in liposomes prepared from proliposomes. DUFOUR, P., VUILLEMARD, J. C., LALOY, E., and SIMARD, R. E., J. Microencapsulation, 1996, 13 (2), 185–194.
  • Evaluation and optimization of different cationic liposome formulations for in vivo gene transfer. EGILMEZ, N. K., IWANUMA, Y., and BANKERT, R. B., Biochem. Biophys. Res. Commun., 1996, 221 (1), 169–173.
  • Non-phospholipid fusogenic liposomes. EL BARAKA, M., PECHEUR, E. I., WALLACH, D. F. H., and PHILPPOT, J. R., Biochim. Biophys. Acta, 1996, 1280 (1), 107–114.
  • Microencapsulation of ketoprofen using w/o/w complex emulsion technique. EL GIBALY, I., SAFWAT, S. M., and AHMED, M. 0., J. Microencapsulation, 1996, 13 (1), 67–87.
  • Double long-chain amidine liposome-mediated self replicating RNA transfection. EL OUAHABI, A., PECTOR, V., FUKS, R., VANDENBRANDEN, M., and RUYSSCHAERT, J. M., FEBS Lett., 1996, 380 (1, 2), 108–112.
  • Advances in targeting treatment with liposomal adriamycin. FENG, B., and Li, D., Zhongguo Yaoxue Zazhi, 1995, 30(9), 518–521.
  • Size-dependent release of carboxyfluorescein from cetylmannoside-modified liposomes in human plasma. FERDOUS, A. J., ISHIDA, T., SHINOHARA, M., HARASHINIA, H., and KIWADA, H., Biopharm Drug Dispos., 1996, 17 (2), 145–154.
  • Coating liposomes with collagen (Mr 50,000) increases uptake into liver. FONSECA, M. J., ALSINA, M. A., and Rem, F., Biochim. Biophys. Acta, 1996, 1279 (2), 259–65.
  • In vitro and in vivo gene transfer to pulmonary cells mediated by cationic liposomes. FORTUNAT, E., BOUT, A., ZANTA, 1VI., VALERIO, D., and SCARPA, M., Biochim. Biophys. Acta, 1996, 1306 (1), 55–62.
  • Effect of incubation time and temperature on aggregation of merocyanine 540 in palmitoyl-oleoyl lecithin liposomes. FRANKOVA, R., and SIKUROVA, L., Acta Phys. Univ. Comenianae, 1993, 34 (2), 219–224.
  • Enhanced therapeutic effect of cytidine-5'-diphosphate choline when associated with GM1 containing small liposomes as demonstrated in a rat ischemia model. FRESTA, M., WEHRLI, E., and PuGus, G., Pharm. Res., 1995, 12 (11), 1769–1774.
  • Endocytosis and intracellular processing accompanying transfection mediated by cationic liposomes. FRIEND, D. S., PAPAHADJOPOULOS, D., and DEBS, R. J., Biochim. Biophys. Acta, 1996, 1278 (1), 41–50.
  • Can superoxide organic chemistry be obsd. within the liposomal bilayer? FRIMER, A. A., STRUL, G., Bucu, J., and GOTTLIEB, H. E., Free Radical Biol. Med., 1996, 20 (6), 843–852.
  • Singlet-oxygen generation from liposomes: a comparison of 6#-cholesterol hydroperoxide formation with predictions from a one-dimensional model of singlet-oxygen diffusion and quenching. Fu, Y., SINIA, P. D., and KANOFSKY, J. R., Photochem. Photobiol., 1996, 63 (4), 468–476.
  • Receptor-mediated endocytosis of poly(acrylic acid)-conjugated liposomes by macrophages. FUNIIWARA, M., BALDESCHWIELER, J. D., and GRUBBS, R. H., Biochim. Biophys. Acta, 1996, 1278 (1), 59–67.
  • Liposome longevity and stability in circulation: effects on the in vivo delivery to tumors and therapeutic efficacy of encapsulated anthracyclines. GABIZON, A., CHEMLA, M., TZEMACH, D., HOROW/TZ, A. T., and GOREN, D., y. Drug Targeting, 1996, 3 (5), 391–398.
  • Thermodynamic approach to protein microencapsulation into poly(DL-lactide) by spray drying. GANDER, B., JOHANSEN, P., NArvi, T. H., and MERKLE, H. P., Int. y. Pharm., 1996, 129 (1, 2), 51–61.
  • Dihydroxyacetone in microspheres. A technical approach to overcome problems in the use of DHA in cosmetic sun products. GARCES, J., BONILLA, A., CORMA, C., PARENTE, A., and GARCIA, A. J. M., Cosmet News, 1995, 18 (105), 520–422.
  • Prolongation of murine cardiac allograft survival by microspheres containing TNF a and IL1-# neutralizing antibodies. GERBER, D. A., °ETTINGER, C. W., D'SouzA, M., 1VIii..ToN, G. V., LARSEN, C. P., and PEARSON, T. c., y. Drug Targeting, 1995, 3 (4), 311–315.
  • Cellulose acetate trimellitate ethyl cellulose blends for non-steroidal anti-inflammatory drug (NSAID) microspheres. GIUNCHEDI, P., TORRE, M. L., MAGGI, L., CONTI, B., and CONTE, U., .7. Microencapsulation, 1996, 13 (1), 89–98.
  • In situ activation of mouse alveolar macrophages by aerosolized liposomal IFM-y and muramyl tripeptide. GOLDBACH, P., DUMONT, S., KESSLER, R., POINDRON, P., and STANIM, A., Am. y. Physiol., 1996, 270 (3, Pt. I), L429–L434.
  • Microencapsulation of drugs by solvent evaporation process. GOTO, S., and UCHIDA, T., Pharm. Tech. Ypn., 1996, 12(3), 393–404.
  • Liposomal vaccines. GREEN, S., FORTIES, A., DIJKSTRA, J., :MADSEN, J., SWARTZ, G., EINCK, L., GURISH, ED., and NAcY, C., Adv. Exp. Med. Biol., 1995, 383 (Immunobiology of Proteins and Peptides VIII)), 83–92.
  • Engineering liposomes for drug delivery: progress and problems. GREGORIADIS, G., Trends Biotechnol., 1995, 13 (12), 327–37. 68 refs.
  • Liposomes as immunological adjuvants for protein and peptide vaccines. GREGORIADIS G., Drug Targeting Delivery, 1995, 6 1–18.
  • Giant liposomes as potential vesicles for live or attenuated microbial vaccines. GURSEL, I., ANTIMISIARIS, NTIMISIARIS., JAYASEKERA, P., and GREGORIADIS, G., Drug Targeting Delivery, 1995, 6 35–50. Plasmodium falciparum: the adherence of erythrocytes infected with human malaria can be mimicked using pfalhesin-coated microspheres. GUTHRIE, N., BIRD, D. NI. K., CRANDALL, I., and SHERMAN, 1. W., Cell Adhes. Commun., 1995, 3 (5), 407–417.
  • Preparation, characterization and in vitro drug release of poly-e-caprolactone and hydroxy-propyl methyl cellulose phthalate ketoprofen loaded microspheres. GUZNIAN, NI., MOLPECERES, J., GARCIA, F., and ABERTURAS, M. R.J. Microencapsulation, 1996, 13 (I), 25–39.
  • Effects of fusogenic and DNA-binding amphiphilic compounds on the receptor-mediated gene transfer into hepatic cells by asialofetuin-labeled liposomes. HARA, T., KuwAs.m.A, H., ARANIAKI, Y., TAKADA, S., KOIKE, K., ISHIDATE, K., KATO, H., and TSUCHIYA, S., Biochim. Biophys. Acta., 1996, 1278 (1), 51–58.
  • Surface modification of microspheres by plasma-graft polymerization. HARAGUCHI, T., YAMADA, K., IDE, S., HATANAKA, C., GOTO, M., KUNIADA, K., HATATE, Y., and KAJIYAMA, T., Kitayushu Kogyo Koto Senmon Gakko Kenkyu Hokoku, 1996, 29 41–46.
  • Size dependent liposome degradation in blood: in vivo/in vitro correlation by kinetic modeling. HARASHIMA, H., HIRAIWA, T., Ocin, Y., and KIWADA, H., _7. Drug Targeting, 1995, 3 (4), 253–261.
  • Studies on the mechanism of uptake of liposomes using an isolated perfused liver system. HARASHIMA, H., and KIWADA, H., y. Liposome Res., 1996, 6 (1), 61–75.
  • Liposomal chemotherapy for AIDS-related Kaposi's sarcoma. HARRISON, NI., HARRINGTON, K. J., and STEWART, J. S. NV., Expert Opin. Invest. Drugs, 1995, 4(12), 1197–1203.
  • Long-term stability of liposomes containing both tissue-type plasminogen activator and glu-plasminogen. HEEREMANS, J. L. NI., MIJNHEER, F. W., GERRITSEN, H. R., PaExos-r, R., KLUFT, C., and CRONINIELIN, D. J. A., Int. J. Pharm., 1996, 129 (1, 2), 191–202.
  • The preparation of tissue-type plasminogen activator (t-PA) containing liposomes: entrapment efficiency and ultracentrifugation damage. HEEREMANS, J. L. NI., GERRITSEN, H. R., NIEUSEN, S. P., MIJNHEER, F. W., PANDAY, R. S. G., PREVOST, R., KLurr, C., and CROMMELIN, D. J. A., _7. Drug Targeting, 1993, 3 (4), 301–310.
  • In vivo colored microspheres in the isolated rat heart for use in NMR. HILLER, H. H., ADAMI, P., VoLL, S., RODER, F., KOWALLIK, P., BALER, NV. R., HAASE, A., and ERTL, G., J. Mol. Cell Cardiol., 1996, 28(3), 571–577.
  • Effect of aging on arteriolar dilatation induced by prostaglandin El incorporated in lipid microspheres. Hi ROSE, M., CHUN, T. Y., and NIIYAZAKI, M., J. Cardiovasc. Pharmacol., 1996, 27(5), 749–751.
  • Generation and analysis of liposome aerosols. Ho, J., Drug Targeting Delivery, 1995, 6 199-208. Virosomes: cationic liposomes enhance retroviral transduction. HODGSON, C. P., and SOLAIMAN, F., Nat. Biotechnol., 1996, 14 (3), 339–342.
  • Study on the pre-metronidazole liposomes and its drug effect by microcalorimetry technology. Hou, X., NING, B., Li, X., and TAN, A., Beijing Yike Daxue Xuebao, 1994, 26 (6), 481–483.
  • Membrane compactness affects the integrity and immunoprotection of alginate-poly(L-lysine)-alginate microcapsules. Hsu, B. R. S., Ho, Y. S., Fu, S. H., HUANG, Y. Y., CHIOU, S. C., and HUANG, H. S., Transplant Proc., 1995, 27 (6), 3227–3231.
  • Coating performance of aqueous composite lattices with N-isopropylacrylamide shell and thermosensitive permeation properties of their microcapsule membranes. ICHIKAWA, H., KANEKO, S., and FUKUNIORI, Y., Chem. Pharm. Bull., 1996, 44(2), 383–391.
  • Normalization of diabetes by xenotransplantation of cryopreserved microencapsulated pan-creatic islets. Application of a new strategy in islet banking. INABA, K., Zliou, D., YANG, B., V.ACEK, I., and SUN, A. NI., Transplantation, 1996, 61(2), 175–179.
  • Microsphere synthesis of polypyrrole by oxidation polymerization. Isnizu, K., TANAKA, H., SArro, Arro., MARUYANIA, T., and YANIANIOTO, T., Polymer, 1996, 37 (5), 863-876. Liposome-mediated BDNF cDNA transfer in intact and injured rat brain. IWANIOTO, Y., YANG, K., CLIFTON, G. L., and HAYES, R. L., Neuro Report, 1996, 7 (2), 609–612.
  • Preparation and evaluation of captopril microspheres by spherical crystallization. JAY.XSWAL, S. B., REDDY, T. S. R., VIJAY, K. M., and KUNIAR, G. V., Indian Drugs, 1995, 32 (9), 454–457.
  • Characteristics and drug release profiles of multilamellar vesicle (MLV) and microemulsified liposome (MEL) containing 5-fluorouracil and its derivatives. JEE, U. K., PARK, M. S., LEE, G. W., and Lyu, Y. G., Yakche Hakhoechi, 1995, 25 (3), 249–264.
  • Location of ubiquinone homologs in liposome membranes studied by fluorescence anisotropy of diphenyl-hexatriene and trimethylammonium-diphenyl-hexatriene., IENHOLA, R. M., KRUK, J., SKOWRONEK, M., and STRZALKA, K., Chem. Phys. Lipids, 1996, 79 (1), 55–63.
  • Effect of solvent removal technique on the matrix characteristics of polylactide/glycolide microspheres for peptide delivery. JEYANTHI, R., THANOO, 13. C., METHA, R. C., and DELUCA, P. P., J. Controlled Release, 1996, 2 (2, 3), 235–244.
  • Phase separation in microcapsule membranes composed of soybean lecithin, cholesterol, stearic acid, and polyvinulpyrrolidone. JoNo, K., ICHIKAWA, H., FUKUNIORI, Y KANAMORI, R., TSUTSUMI, Y., MURATA, K., Moamo-ro, A., and NAKAMURA, K., Chem. Pharm. Bull., 1996, 44 (2), 392–398.
  • Membrane thickness of microcapsules generated by complex coacervation method. KAGE, H., YADA, N., KUNIMASA, M., OGURA, H., and MATSUNO, Y Kagaku Kogaku Ronbunshu, 1996, 22 (2), 342–349.
  • Targeting chemotherapy for malignant brain tumor using thermosensitive liposome and localized hyperthertnia. KAKINUMA, K., TANAKA, R., TAKAHASHI, H., WATANABE, M., NAKAGAWA, T., and KUROKI, M., y. Neurosurg., 1996, 84 (2), 180–184.
  • Preparation and structural characterization of hydrogel microspheres. KANIIJO, Y., FUJIMOTO, K., KAWAGUCHI, H., YUGUCHI, Y., URAKAWA, H., and KIJIWARA, K., Polym. J. (Tokyo), 1996, 28 (4), 309–316.
  • Preparation and characterization of conjugates of (modified) human serum albumin and lipsomes: drug carriers with an intrinsic anti-HIV activity. KAMPS, J. A., SWART, P. J., MORSELT, H. W., PAUWELS, R., DE BETHUNE, M. P., DE CLERCQ, E., MEIJER, D. K., and SCHERPHOF, G. L., Biochim. Biophys. Acta, 1996, 1278 (2), 183–190.
  • Preparation and stability of interferon-a-containing liposomes. KARAU, C., PETSZULAT, NI., and SCHNIIDT, P. C., Int. y. Pharm., 1996, 128 (1, 2), 89–98.
  • Targeted cancer chemotherapy with arterial microcapsule chemoembolization: Review of 1013 patients. KATO, T., SATO, K., SASAKI, R., KAKINUNIA, H., and MORIYANIA, NI., Cancer Chemother. Pharmacol., 1996, 37 (4), 289–296.
  • Nickel/microcapsules composite electrocoatings; the synthesis of water-containing micro-capsules and preparation of the coatings. KENTEPOZIDOU, A., KIPARISSIDES, C., KOTZIA, F., KOLLIA, C., and SPYRELLIS, N., y. Mater. Sci., 1996, 31 (5), 1175–1181.
  • Free versus liposome-entrapped streptomycin sulfate in treatment of infections caused by Salmonella enteritidis. KHALIL, R. M., MURAD, F. E., YEHIA, S. A., EL RIDY, M. S., and SALANIA, AsH. A, Pharmazie, 1996, 51(3), 182–184.
  • Preparation and lectin binding characteristics of N-stearyl lactobionamide liposomes. Kim, C. K., MIN, K. H., OH, Y. K., PARK, K. M., and KIM, K. M., Int. J. Pharm., 1996, 128 (1, 2), 65–71.
  • Preparation of biodegradable microspheres containing water-soluble drug, P-lactam antibiotic. KIN, J. H., KWON, I. C., KIM, Y. H., LA SUNG, B., SOH, Y. T., and JEONG, S. Y., Arch. Pharmacal. Res., 1996, 19 (1), 30–35.
  • Microencapsulation properties of gum arabic and several food proteins: spray-dried orange oil emulsion particles. Ktm, Y. D., and IVIoaa, C. V., J. Agric. Food Chem., 1996, 44 (5), 1314–1420.
  • Microencapsulation properties of gum arabic and several food proteins: liquid orange oil emulsion particles. Kim, Y., MORE, C. V., and SCHENZ, T. W., J. Agric. Food Chem., 1996, 44 (5), 1308–1313.
  • Long-term amelioration of rat adjuvant arthritis following systemic elimination of macro-phages by clodronate-containing liposomes. KINNE, R. W., SCHMIDT, W. C. B., HOPPE, R., BUCHNER, E., PALOMBO, K. E., NUERNBERG, E., and ENINIRICH, F., Arthritis Rheum., 1995, 38 (12), 1777–1790.
  • Cerebral blood flow measured with intracerebral laser-Doppler flow probes and radioactive microspheres. KIRKEBY, 0. J., RISE, I. R., NORDSLETTEN, L., SKJELDAL, S., HALL, C., and RISOE, C., J. Appl. Physiol., 1995, 79 (5), 1479–1486.
  • Liposomal ATP protects the liver from injury during shock. KONNO, H., MATIN, A. F. M., MAauo, Y., NAKAMURA, S., and BABA, S., Eur. Surg. Res., 1996, 28 (2), 140–145.
  • Microencapsulation of orange oil by spray drying. KOTHA, G., and PA, J. S., PAFAI y., 1993, 15(1), 15–18.
  • Liposomal benzoporphyrin derivative verteporfm photodynamic therapy. Selective treat-ment of choroidal neovascularization in monkeys. KRAMER, M., MILLER, J. W., MICHAUD, M., MOULTON, R. S., HASAN, T., FLOTTE, T. J., and GRAGOUDAS, E. S., Ophthalmology, 1996, 103 (3), 427–438.
  • Liposome-encapsulated (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine for long-acting therapy of viral retinitis. KUPPERNIANN, B. D., ASSIL, K. K., VUONG, C., BESEN, G., WILEY, C. A., CLEREQ, E. DE, BERGERON, L. G., CONNOR, J. D., PURSLEY, M., et al., y. Infect. Dis., 1996, 173 (1), 18–23.
  • Adjuvant therapy for osteosarcoma in dogs: results of randomized clinical trials using combined liposome-encapsulated muramyl tripeptide and cisplatin. KURZA/AN, I. D., A/Lc EWEN, WEN. G., ROSENTHAL, R. C., Fox, L. E., KELLER, E. T., HELFAND, S. C., VAIL, D. M., DURIELZIG, R. R., MADEWELL, B. R. et al., Clin. Cancer Res., 1995, 1(12), 1595–1601.
  • Measurement of mouse anti-phospholipid antibodies to solid-phase microspheres by both flow cytofluorometry and Alcian blue-pretreated microtiter plates in a ELISA. LAAKEL, M., BOUCHARD, NI., and LAGACE, J.,.7. Immunol. Methods, 1996, 190 (2), 267–273.
  • Liposomes-an industrial view. LASIC, D., Chem. Ind. (London), 1996, (6), 210–214.
  • Handbook of nonmedical applications of liposomes, volume I: theory and basic sciences. LASIC, D. D., and YECHEZKEL, B., Editors. (CRC, Boca Raton, Fla.), 1996, 331 pp.
  • Handbook of nonmedical applications of liposomes, volume IV: from gene delivery and diagnostics to ecology. LASIC, D. D., and YECHEZKEL, B., Editors. (CRC, Boca Raton, Fla.), 1996, 328 pp.
  • Doxorubin in sterically stabilized liposomes. LASIC, D. D., Nature (London), 1996, 380 (6574), 561–562.
  • Targeted delivery to the pilosebaceous unit via liposomes. LAUER, A. C., RANIACHANDRAN, C., LIES, L. M., NIENIIEC, S., and WEINER, N. D., Adz,. Drug Delivery Rev., 1996, 18 (3), 311–324.
  • Core-shell functional microspheres by dispersion polymerization. 2. Synthesis and character-ization. LACS, M., DINNELLA, C., LANZARINI, G., and CASAGRANDE, A., Polymer, 1996, 37 (2), 343–347.
  • Antitumor effect of mitoxantrone-containing liposomes. LAW, S. L., Ho, C. K., JANG, T. F., CHANG, P., and LiN, F. NI., Int. J. Pharm., 1996, 128(1, 2), 139–143.
  • S-thiolation and oxidation of glycogen phosphorylase band peroxidation of liposome initiated by free radical species. LEE, K. S., LEE, H. M., PARK, Y. M., CHANG, B. D., CHUNG, T. Y., and Cm', E. M., 1. Biochem. Mol. Biol., 1996, 29 (1), 81–87.
  • Delivery of macromolecules into cytosol using liposomes containing hemolysin from Listeria monocytogenes. LEE, K. D., OH, Y. K., PORTNOY, D. A., and SWANSON, J. A.,.7. Biol. Chem., 1996, 271 (13), 7249–7252.
  • Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer. LEE, R. J., and HUANG, L.,.7. Biol. Chem., 1996, 271 (14), 8481–8487.
  • Gelatin microspheres in oil in water multiple emulsion of pingyangmycin. Li, H., WEI, S., and Lu, W., Zhongguo Yaoxue Zazhi, 1995, 30 (10), 600–603.
  • Synthesis of drug carrier: a copolymer microsphere of starch maleic acid ester. Li, L., Hou, X., and SHENG, H., Beijing Yike Daxue Xuebao, 1995, 27 (5), 393–395.
  • Comparison of pharmacokinetics and tissue distribution between cytarabine and cytarabine liposome in rats and dogs. Liu, B., and XIA, D., Zhongguo Yaoxue Zazhi, 1995, 30(10), 615–617.
  • Antibody dependent, complement mediated liver uptake of liposomes containing GMl. Liu, D., SONG, Y. K., and LiL, F., Pharm. Res., 1995, 12 (11), 1775–1780.
  • Animal species dependent liposome clearance. Liu, D., 7. Liposome Res., 1996, 6 (1), 77–97.
  • Liposome clearance: how much do we know about the biological factors that control the process? Liu, D., y. Liposome Res., 1996. 6(1), 1–17.
  • Serum-independent liposome uptake by mouse liver. Liu, F., and LIU, D., Biochim. Biophys. Asia, 1996, 1278 (1), 5–11.
  • SOD-like activities of SOD and Cu(II) complexes in liposomes. Liu, Y., Li, L. T., and Lu, J. S. C. 5,7. Chin. Pharm. Sci., 1995, 4(4), 177–180.
  • SOD-like activity of SOD and Cu(II) complexes in liposomes. Lit:, Y., SUN, J., Li, L., and Lu, C., Beijing Yike Dasue Xuebao, 1995, 27 (4), 319–320.
  • Continuous millimeter-wave radiation has no effect on lipid peroxidation in liposomes. LOGANI, M. K. and ZISKIN, M, C., Radial. Res., 1996, 145 (2), 231–235.
  • Compaction of composites with hollow microspheres. LOPATIN, V. Y., Lze, Vyssh Uchebn Zaved, Tsvetn Metal, 1996, (1), 68–71.
  • Formation and characterization of liposomes from lipid/proteic material extracted from pig stratum corneum. LOPEZ, 0., DE LA XIAZA, A., CODERCH, L., and PARRA, J. L., y. Am. Oil. Chem. Soc., 1996, 73 (4), 443–448.
  • Formulation optimization of novel multicomponent photoprotective liposomes by using response surface methodology. LOUKAS, Y. L., Analyst (Cambridge, UK), 1996, 121 (3), 279–284.
  • Liposomes prepared from inverse micelles. Lu, Z., Wu, Y., and ZHANG, B., Gaodeng Xuexiao Huaxue Xuebao, 1995, 16(11, Suppl.), 116–119.
  • Aggregation of ligand-modified liposomes by specific interactions with proteins. I: biotinylated liposomes and avidin. LYNCII, N. J., KILPATRICK, P. K., and CARBONELL, R. G., Biotechnol Bioeng., 1996, 50 (2), 151–168.
  • Aggregation of ligand-modified liposomes by specific interactions with proteins. II: bio-tinylated liposomes and antibiotin antibody. LYNCH, N. J., KILPATRICK, P. K., and CARBONELL, R. G., Biotechnol. Bioeng., 1996, 50 (2), 169–183.
  • Microencapsulation reactor scale-up by dimensional analysis. MAA, Y. F., and Hsu, C., 7. Microencapsulation, 1996, 13 (1), 53–66.
  • Effects of orally administered liposomes with soybean-derived sterols and their glucosides on rat body weight. MAITANI, Y., HAZANIA, M., TOJO, H., Qi, X. R., and NAGAI, T., Biol. Pharm. Bull., 1995, 18(11), 1551–1555.
  • Oral administration of recombinant human erythropoietin in liposomes in rats: influence of lipid composition and size of liposomes on bioavailability. MAITANI, Y., HAZANIA, M., TOJO, Y., SHINIODA, N., and NAGAI, T., J. Pharm. Sc., 1996, 85 (4), 440–445.
  • Synthesis of 1,4-dihydropyridine derivatives containing an N-alkylpyridinium substituent in position 4 and their affinity for liposomal membranes. 1VIAKARovA, N. V., KORONOVA, Z. V., PLOTNIECE, A. V., TIRZITE, D. Y., TIRZIT, G. D., and DUBURS, G. Y., Khim Geterotsikl Soedin, 1995, (8), 1112–1117.
  • Specific hybrid liposomes composed of phosphatidylcholine and polyoxyethylenealkyl ether with markedly enhanced inhibitory effects on the growth of tumor cells in vitro. MATsumoTo, Y., IMANIURA, C., ITO, T., TANIGUCHI, C., and UEOKA, R., Biol. Pharm. Bull., 1995, 18 (10), 1456–1458.
  • Gene transfer to the retina of rat by liposome eye drops. MATsuo, T., MASUDA, I., YASUDA, T., MATsuo, N., Biochem. Biophys. Res. Commun., 1996, 219 (3), 947–950.
  • Liposomal methylprednisolone in rats: dose-proportionality and chronic-dose pharmaco-kinetics/pharmacodynamics. MisFuNA, E. V., and JusKo, W. J., Pharm. Res., 1996, 13 (1), 141-145. Glass microsphere laser. MivaA, K., and HIRAO, K., Kino Zairyo, 1996, 16(3), 5–11.
  • Histological analysis of microencapsulated dopamine-secreting cells in agarose/poly(styrene sulfonic acid) mixed gel xenotransplanted into the brain. MIYOSHI, Y., DATE, I., OHNIOTO, T., and IWATA, H., Exp. Neurol., 1996, 138 (1), 169–175.
  • Application of fusogenic liposomes containing fragment A of diphtheria toxin to cancer therapy. Mizucucm, H., NAKANISHI, M., NAKANISHI, T., NAKAGAWA, T., NAKAGAWA, S., and MAyumt, T., Br. J. Cancer, 1996, 73 (4), 472–476.
  • Intratumor administration of fusogenic liposomes containing fragment A of diphtheria toxin suppresses tumor growth. Mizucuan, H., NAKANISHI, T., NAKANISHI, M., NAKAGAWA, T., NAKAGAWA, S., and MAvuNn, T., Cancer Lett. (Shannon, Irel)„ 1996, 100 (1, 2), 63–69.
  • DNA/liposome as drug delivery system in the gene therapy. NhzuNo, M., and YOSHIDA, J., Drug Delivery Syst., 1995, 10 (6), 399–403.
  • Oxidative stability of anhydrous milkfat microencapsulated in whey proteins. MOREAU, D. L., and ROSENBERG, NI., J. Food Sc., 1996, 61(1), 39–43.
  • In vivo antitumor activity of cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane pla-tinum(II) formulated in long-circulating liposomes. Mom, A., Wu, S. P., HAN, I., KHOKHAR, A. R., PEREZ, S. R., and HUANG, L., Cancer Chemother. Pharmacol, 1996, 37 (5), 435–444.
  • The effect of liposomal dose on the intracellular fate of liposomes in rats in vivo. MORIOKA, Y., HARASHIMA, H., YOSHINIUA, K., and KIWADA, H., Drug Delivery Syst., 1996, 11(1), 27–35.
  • Microencapsulation of antitumor, antibiotic and thrombolytic drugs in microgravity. MORRISON, D. R., MOSIER, B., and CASSANTO, J., NASA Conf. Publ., 1994, 3249 (Technology 2003, Vol. 1), 117–126.
  • In vivo behavior of liposomes modified with a novel galactosyllipid derivative. MURAHASHI, N., and SASAKI, A., Biol. Pharm. Bull, 1996, 19 (3), 418–423.
  • Cardioprotection by liposome-conjugated sialyl Lewisx-oligosaccharide in myocardial ischemia and reperfusion injury. MuaonAaA, T., MARGIoTTA, J., PHILLIPS, L. M., PAULSON, J. C., DEFREES, S., ZALIPSKY, S., Guo, L. S. S., and LEFER, A. M., Cardiovasc. Res., 1995, 30 (6), 965–974.
  • Feasibility of topical liposome drugs produced on an industrial scale. NAEFF, R., Adv. Drug Delivery Rev., 1996, 18 (3), 343–347.
  • Membrane-damaging action of Clostridium perfringens alpha-toxin on phospholipid lipo-somes. NAGAHAMA, M., MICHIUE, K., and SAKURAI, J., Biochim. Biophys. Acta, 1996, 1280 (1), 120–126.
  • Viscoelastic properties of hydrogel microcapsule membranes. NAGAse, Y., KITA, R., DOBASI-11, T., and KONDO, T., Polym. Gels Networks, 1996, 4(1), 7–15.
  • Ovalbumin-liposome conjugate induces IgG but not IgE antibody production. NAITO, S., HORINO, A., NAKAYANIA, M., NAKANO, Y., NAGAI, T., IVIizucucEn, J., KONIURO, K., and UCHIDA, T., Int. Arch. Allergy Immunol., 1996, 109 (3), 223–228.
  • Extraction of taste receptor protein by artificial boundary lipid-containing liposome. NAKA-MURA, M., TSUJII, K., and SUNANIOTO, J., Nippon Au to Nioi Gakkaishi, 1995, 2 (3), 393–395.
  • Incorporation of the lipopolysaccharide and polysaccharide from Aeromonas salmonicida into liposomes. NAKHLA, N., BANOUB, J. H., HERNANDEZ, B. J., and KEOUGH, K. M. W., y. Liposome Res., 1996, 6 (1), 141–154.
  • Biodegradable microspheres using two different gelatin drug conjugates for the controlled delivery of methotrexate. NARAYANI, R., and RAO, K. P., Int. y. Pharm., 1996, 128(1, 2), 261-268. Microencapsulation of chloroquinone diphosphate by Eudragit RS100. NDESENDO, V. M. K., MEIXNER, EIXNER., KORSATKO, W., and KORSATKO, W. B., J. Microencapsulation, 1996, 13 (1), 1–8.
  • Raman spectroscopy investigation of the interaction of delta-lysin with phospholipid lipo-some. NET-rcnev, V. Z., Dokl Bulg Akad Nauk, 1995, 48 (5), 79–82.
  • Study on the in vitro stability of polymerized liposomes. NISHIYA, T., and JAIN, B., Artif. Cells, Blood Substitutes, Immobilization Biotechnol., 1996, 24 (1), 43–50.
  • Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma. NORTHFELT, D. W., MARTIN, F. J., WORKING, P., VOLBERDING, P. A., RUSSELL, J., NEWNIAN, INI.„ANLANTEA, M. A., and KAPLAN, L. D.,.7. Clin. Pharmacol., 1996, 36 (1), 55–63.
  • The reversible aggregation-disaggregation and fusion of phosphatidylcholine liposomes with and without polyethylene glycol. OGIHARA, T., TAKANIOTO, Y KUNIAZAWA, H., and HAYASHI, H., Seibutsu Butsuri Kagaku, 1996, 40(1), 7–12.
  • Optimal radiolabelled liposomes for tumor imaging. OGIHARA, U., SASAKI, T., KOJIMA, S., and Nisincoal, isincoal.,Nucl. Med., 1996, 37 (2), 326–332.
  • Can the microsphere model be applied to cerebral blood flow measurement using N-isopropyl-p-(1231)iodoamphetamine with SPET regardless of washout from brain tissue? OHKUBO, NI., ODANO, I., TAKAI1ASHI, N., and SAKAI, K., Nucl. Med. Commun., 1995, 16 (12), 1026–1033.
  • A quantitative in vivo method of analyzing human tumor-induced angiogenesis in mice using agarose microencapsulation and hemoglobin enzyme-linked immunosorbent assay. OKADA, N., FUSHINII, M., NAGATA, Y., FUKUNAGA, T., TSUTSUNII, Y NAKAGAWA, S., and MAYUNII, T., jpn. y. Cancer Res., 1995, 86 (12), 1182–1188.
  • Effect of serum protein binding on real-time trafficking of liposomes with different charges analyzed by positron emission tomography. OKu, N., TOKUDONIE, Y NANIBA, Y., SAITO, N., ENDO, M., HASEGAWA, Y., KAws, M., TSUKADA, H., and OKADA, S., Biochirn. Biophys. Acta, 1996, 1280 (1), 149–54.
  • Device for studying hydrostatic strength of microsphere plastics. OLKHOVIC, 0. E., Zavod. Lab., 1996, 62 (2), 52–55.
  • Synthetic hollow aluminophosphate microspheres. OLIVER, S., COONIBS, N., and OZIN, G. A., Adv. Mater. (Weinheim, Ger), 1995, 7(11), 931–935.
  • Incorporation, release and in-vitro antibacterial activity of liposomal aminoglycosides against Pseudomonas aeruginosa. ONIRI, A., RAVAOARINORO, M., and POISSON, M., j . Antimicrob. Chemother., 1995, 36 (4), 631–639.
  • Comparison of the bactericidal action of amikacin, netilmicin and tobramycin in free and liposomal formulation against Pseudomonas aeruginosa. ONIRI, A., and RAVAORINORO, M., Chemotherapy (Basel), 1996, 42 (3), 170–176.
  • Cisplatin incorporated in microspheres, the development and fundamental studies for its clinical application. ()SAKI, K., Kyoto-furitsu Ika Daigaku Zasshi, 1995, 104 (11), 1225-1240. Formulation and release kinetics of cephalexin monohydrate from biodegradable poly-meric microspheres. Owusu, A. G., and ROGERS, J. A.,Microencapsulation, 1996, 13 (2),195–205.
  • Liposomes in ocular drug delivery. OZER, A. V.. FABAD Farm Balmier Derg, 1995, 20 (4), 173–180.
  • On the compressive elasticity of epoxy resins filled with hollow glass microspheres. PALUNIBO, M., DONZELLA, G., TENIPESTI, E., and FERRUTI, P.,.7. Appl. Polym. Sc., 1996, 60 (1), 47–53.
  • Application of 99mTc labeling for fast comparative screening of preformed liposomes in vivo. PANAGI, Z., SAWAS, D. C.„AVGOUSTAKIS, K., and ITHAKissios, D. S., Drug Dev. Ind, Pharm., 1996, 22 (3), 217–224.
  • Mechanism of hypochloride-induced peroxidation in phosphilipid liposomes. PANASENKO, 0. M., and ARNHOLD, J., Biol. Membr., 1996, 13 (1), 89–99.
  • Toxicological aspects of the use of dextran microspheres and thermogelling ethyl hydroxy-ethyl cellulose (EHEC) as nasal drug delivery systems. PERESWETOFF, M. L., BJURSTROM, S., KHAN, R., DAHLIN, M., and EDNIAN, P., bit. j. Pharm., 1996, 128 (1, 2), 9–21.
  • Immunological consequences of nasal drug delivery in dextran microspheres and ethyl-(hydroxyethyl)cellulose in rats. PERESWETOFF, M. L., and EDNIAN, P., Int. y. Pharm., 1996, 128 (1, 2), 23–28.
  • Pharmacodynamics of a liposomal preparation for local anaesthesia. PETERS, H., and MOLL, F., Arzneimittelforschung, 1995, 45 (12), 1253–1256.
  • ATP synthesis by the FOFI ATP synthase from thermophilic Bacillus PS3 reconstituted into liposomes with bacteriorhodopsin. Part 1. Factors defining the optimal reconstitution of ATP synthases with bacteriorhodopsin. PITARD, B., RICHARD, P., DUNACH, M., GIRAULT, G., and RIGAUD, J. L., Eur. y. Biochem., 1996, 235 (3), 769–778.
  • Change in the N-terminal domain conformation of annexin I that correlates with liposome aggregation is impaired by Ser-27 to Glu mutation that mimics phosphorylation. PORTE, F., DE SANTA, B. P., PHALIPOU, S., LIAUTARD, J. P., and WIDADA, J. S., Biochim. Biophys. Acta, 1996, 1293 (2), 177–184.
  • Quality control of 99mTc-labeled microspheres for studies of the pulmonary blood circulation. POTAPOVA, OTAPOVA. M., EPSTEIN, N. B., STAROVOYTOVA, L. P., KHARITONOV, Y. Y., KHLESKOV, V. I., KHARLAMOV, V. T., and SKVORSOV, V. G., Pharm. Pharmacol. Lett., 1995, 5 (4), 135–138.
  • Animal experiment and clinical trial of hepatic artery chemoembolization with cisplatin microspheres in the treatment of hepatocellular carcinoma. Pu, Z., ZFIAO, Y., ZHU, J., Y1, B., XUE, W., QIE, X., WANG, Y., and SHI, T., Beijing Yike Daxue Xuebao, 1995, 27 (5), 381–383.
  • Preparation and characterization of Fe304/P(St-AA) core-shell composite microspheres. Q: u, G., GAO, X., YANG, C., and SUN, Z., Yingyong Huaxue, 1996, 13(1), 6–9.
  • Microencapsulation of isocyanates. Characterization, and storage stability of microcapsules in a polyester a-hivin, w-ol. QUERAT, E., TIGHZERT, L., and PASCAULT, J. P.,.7. Coat. Technol., 1996, 68 (854), 83–90.
  • Formation of oily microcapsules by complex coacervation. RABISKOVA, M., Ceska. Slov. Farm., 1996, 45 (1), 17–18.
  • Enhancement of liposome-mediated gene transfer into vascular tissue by replication deficient adenovirus. RAJA, W. R., WEBBER, J., NAFTILAN, J., CHAPMAN, G. D., and NAFTILAN, A. J., Gene. Ther., 1995, 2 (8), 521–530.
  • Liposome preparation methods. RIAZ, M., Pak. 1. Pharm. Sci., 1996, 9 (1), 65–77.
  • Intramuscular fate and local effects of liposomes as carriers for drugs and vaccines. RICHARDS, R. L., HAILEY, J. R., EGAN, J. E., GORDON, D. M., JOHNSON, A. J., ALVING, C. R., WASSEF, N. M., Drug Targeting Delivery, 1995, 6 167–178.
  • The effect of posture on nasal clearance of bioadhesive starch microspheres. RIDLEY, D., PERKINS, A. C., WASHINGTON, N., WILSON, C. G., WASTIE, M. L., O'FLYNN, P., BLATTMAN, A., PONCHEL, G., and DUCHENE, D., STP Pharma. Sci, 1995, 5 (6), 442–446.
  • Differing features of proteins in membranes may result in antioxidant or pro-oxidant action: opposite effects on lipid peroxidation of alcohol dehydrogenase and albumin in liposomal systems. RIEDL, A., SHAMSI, Z., ANDERTON, M., GOLDFARB, P., and WISENIAN, A., Redox. Rep., 1996, 2 (1), 35–40.
  • Multiple responses to administration of liposome-encapsulated hemoglobin (LEH): effects on hematopoiesis and serum IL-6 levels. RoLLwAGEN, F. M., GAFNEY, W. C., PACHECO, N. D., DAVIS, T. A., HICKEY, T. M., NIELSEN, T. B., and RUDOLPH, A. S., Exp. Hematol., 1996, 24 (3), 429–436.
  • Microencapsulation of volatiles by spray-drying in whey protein-based wall systems. ROSENBERG, NI., and SHEU, T. Y., Int. Dairy J., 1996, 6 (3), 273–284.
  • Dissociation of cytochrome c from liposomes by histone HI. Comparison with basic peptides. RYTOEMAA, M., and KINNUNEN, P. K., Biochemistry, 1996, 35 (14), 4529–4539.
  • Effect of microcapsule size and polyisobutylene concentration on the release of theophylline from ethylcellulose microcapsules. SA, B., BANDYOPADHYAY, A. K., and GUPTA, B. K., y. Microencapsulation, 1996, 13 (2), 207–218.
  • A novel method of preparing PLGA microcapsules utilizing methyl ethyl ketone. SAII, H., SMITH, M. S., and CHERN, R. T., Pharm. Res., 1996, 13 (3), 360–367.
  • Congo red attached poly(EGDMA-HEMA) microspheres as specific sorbents for removal of cadmium ions. SALIH, B., DENIZLI, A., ENGIN, B., TUNCEL, A., and PISKIN, E.,.7. Appl. Polym. Sci., 1996, 60 (6), 871–877.
  • Targeting of cationic liposomes to skin-associated bacteria. SANDERSON, N. M., and JONES, M. N., Pestic. Sci., 1996, 46(3), 255–261.
  • Uptake of fluorescent oligonucleotides encapsulated in liposomes by cultured keratinocytes and their intracellular delivery process. SASAKI, M., WATANABE, M., KAWAKUBO, Y., KOMIYAMA, M., KOBAYASIII, M., and FUJITA, H., Photomed. Photobiol., 1995, 17, 103–104.
  • Polyacrylamide microcapsules: Multipurpose drug carriers. SAWANT, K. K., and MURTHY, R. S. R, Indian J. Hosp. Pharm., 1995, 32 (3), 96–97.
  • Interaction of liposomes with human skin: the role of the stratum corneum. SCHALLER, M., and KORTING, H. C., Adv. Drug Delivery Rev., 1996, 18 (3), 303–309.
  • Cells involved in removing liposomes from the blood circulation: why are they so special? SCIIERPHOF, G. L., and CROMMELIN, D. J. A., y. Liposome Res., 1996, 6 (1), 19–32.
  • Therapeutic progress with topical liposome drugs for skin disease. SCHMIDT. NI. H., and KORTING, H. C., Adv. Drug Delivery Rev., 1996, 18 (3), 335–342.
  • Oral antitumor activity in murine L1210 leukemia and pharmacological properties of liposome formulations of N4-alkyl derivatives of 1-beta-D-arabinofuranosylcytosine. SCHWENDENER, R. A., HORBER, D. H., ODERMATT, B., and SCH017, H., y. Cancer Res. Clin. Oncol., 1996, 122 (2), 102–108.
  • Antigens linked to synthetic microspheres induce immune responses in primates in the absence of adjuvant. SEDLIK, C., PERRAUT, R., BONNEMAINS, B., and LECLERC, C., Immunobiology (Stuttgart), 1996, 195 (1), 105–118.
  • Liposome-blood protein interactions in relation to liposome clearance. SEMPLE, S. C., and CHONN, A., y. Liposome Res., 1996, 6 (1), 33–60.
  • Influenza virus-liposome lipid mixing is leaky and largely insensitive to the material properties of the target membrane. SILANGGUAN, T., ALFORD, D., and BENTZ, J., Biochemistry, 1996, 35 (15), 4956–4965.
  • Liposome-mediated immune response: cellular requirements and immunomodulation by bifunctional liposomes. SHEK, P. N., and SABISTON, B. H., Drug Targeting Delivery, 1995, 6, 19–34.
  • Liposomes in biomedical applications. (Proceedings of the defense research liposome workshop held in Toronto, 13–14 October, 1993.). (Drug Targeting Delivery, SHEK, P. N., Ed., Harwood: Lausanne, Switz.), 1995, 280 pp.
  • Study on the size and stabilty of lung surfactant liposomes prepared by sonication method. SHI, M. W., LAW, S. L., and TSAY, R., yiemian Kexue Huizhi, 1995, 18 (4), 251–259.
  • Determination of the thickness of the fixed aqueous layer around polyethylene glycol-coated liposomes. SHINIADA, K., MIYAGISHINIA, A., SADZUKA, Y NozAw A, Y MOCHIZUKI, Y., OHSHINIO, H., and HiaoTA, S., J. Drug Targeting, 1995, 3 (4), 283–289.
  • Fatty acyl-Co A: sphingosine acyltransferase in bovine brain mitochondria: its solubilization and reconstitution onto the membrane lipid liposomes. SnimExo, H., SOEDA, S., YASUKOUCHI, M., OK.ANIURA, N., and NAGA:MATSU, A., Biol. Pharm. Bull., 1995, 18 (10), 1335–1339.
  • Liposome-coated local anesthetics and opioids: a pharmacotechnicological advance in progress. SimoNerri, M. Dos P. B., and PAVAN DE A. M., Rev. Bras. Anestesiol, 1996, 46 (1), 35–42.
  • Constitution and stabilization of retinal Schiff bases in phosphatidylchloline liposomes. SINGH, A. K., and DAS J., Indian, j. Chem., Sect. B: Org Chem. Incl. Med. Chem., 1996, 35B(3), 187–194.
  • Application of antibody and fluorophore-derivatized liposomes to heterogeneous immuno-assays for D-dimer. SINGH, A. K., KILPATRICK, P. K., and CARBONELL, R. G., Biotechnol. Prog., 1996, 12 (2), 272–280.
  • In vitro studies with liposomal cryptolepine. SINGH, M., SINGH, M. P., and ABLORDEPPEY, S., Drug Dev. Ind. Pharm, 1996, 22 (4), 377–381.
  • Stimulation of movement and acrosome reaction of human spermatozoa by PC12 liposomes encapsulating ATP. SKII3A, L. M., AUGER, J., TERRIBILE, J., FATTAL, E., DELATTRE, J., PUISIEUX, F., and Jot:ANNET, P., Int. y. Androl, 1995, 18 (6), 287–294.
  • Qualitative and quantitative characterization of a microencapsulated protein with pyrolysis-atmospheric pressure ionization mass spectrometry. SNYDER, A. P., Chemon. Intell. Lab. Syst., 1996, 32 (2), 233–243.
  • Liposomal cefoxitin in a porcine model of intra-abdominal sepsis: bactericidal efficacy. SOLTES, S., MUSTARD, R. A., SHEK, P. N., FLORIO, E., BOHNEN, J. M., and NIITTELMAN, M. W Shock, 1995, 4 (5), 373–378.
  • Liposomal DNA delivery. SoN, K., and HUANG, L., Drug Targeting Delivery, 1995, 4 321-336. Liposomal encapsulation increases the activity of the topoisomerase I inhibitor topotecan. SUBRANIANIAN, D., and MuLLER, M. T., Oncol. Res., 1995, 7 (9), 461–469.
  • Inhibition of tumor growth by direct intratumoral gene transfer of herpes simplex virus thymidine kinase gene with DNA-liposome complexes. SUGAYA, S., FUJITA, K., KIKUCHI, A., UEDA, EDA., TAKAKUWA, K., KODANIA, S., and TANAKA, K., Hum. Gene. Ther., 1996, 7 (2), 223-230. Preparation and characterization of poly(methyl methacrylate) microspheres modified with both glucose and phosphorylcholine moieties. SUGIYAMA, K., Me, T., and OHGA, K., Kobinshi Ronbunshu, 1996, 53 (2), 115–122.
  • Stability of dry liposomes in sugar glasses. SUN, W. Q., LEOPOLD, A. C., CROWE, L. M., and CROWE, J. H., Biophys. 7., 1996, 70 (4), 1769–1776.
  • Immobilized chymotrypsin on reversibly precipitable polymerized liposome. SUN, Y JIN, X. H., DoNG, X. Y., Yu, K., and ZHOU, X. Z., App. Biochem. Biotechnol., 1996, 56 (3), 331-339. Liposome-associated antioxidants for pulmonary applications. SuNTREs, Z. E., and SHEK, P. N., Drug Targeting Delivery, 1995, 6 179–198.
  • Effects of glucose and its oligomers on the stability of freeze-dried liposomes. SUZUKI, T., KONIATSU, H., and MIYAJINIA, K., Biochim. Biophys. Acta., 1996, 1278 (2), 176–182.
  • Preparation of reactive polymeric microspheres by seeded copolymerization using a poly-merizable surfactant bearing an active ester group. TAKAHASHI, K., and NAGAI, K., Polymer, 1996, 37 (7), 1257–1266.
  • The selective antitumor effect of immuno-cherno-liposomes on hamster osteosarcoma. TAKEUCHI, H., Tokyo Yikeikai Ika Daigaku Zasshi, 1996, 111 (1), 49–56.
  • Microencapsulation of heat-storage materials. TANAKA, M., KIMURA, I., and FUKUDA, E., Kemikaru Enjiniyaringu, 1996, 41(2), 151–157.
  • Antitumor effect of liposome-entrapped carboplatin administered via the portal vein in rats. TERADA, J., MIZUNO, I., MANABE, T., YOTSUYANAGI, T., and MoHai, N., Drug Delivery Syst., 1996, 11(1), 21–25.
  • Differential biodistribution of encapsulated and surface-linked liposomal antigens. THERIEN, H. M., and SHAHUM, E., Biochim. Biophys. Acta, 1996, 1280 (1), 91–97.
  • A contribution to overcoming the problem of residual solvents in biodegradable microspheres prepared by coacervation. THONIASIN, C., JOHANSEN, P., ALDER, R., BEMSEL, R., HOTTINGER, G., ALTOREER, LTOREER., WRIGHT, A. D., WEHRLI, G., Meam...E, H. P., and GANDER, B., EU?' J. Pharm. Biopharm., 1996, 42 (1), 16–24.
  • Triggerable plasmalogen liposomes: improvement of system efficiency. THOMPSON, D. H., GERASIMOV, 0. V., WHEELER, J. J., Rui, Y., and ANDERSON, V. C., Biochim. Biophys. Acta, 1996, 1279 (1), 25–34
  • Antitumor activity of vincristine encapsulated in glucuronide-modified long-circulating liposomes in mice bearing Meth A sarcoma. TOKUDOME, Y., OKU, N., Doi, K., NAMBA, Y., and OKADA, S., Biochim. Biophys. Acta, 1996, 1279 (1), 70–74.
  • How do polymers prolong circulation time of liposomes. TORCHILIN, V. P., J. Liposome Res., 1996, 6(1), 99–116.
  • Formulation of BCNU-loaded microspheres: influence of drug stability and solubility on the design of the microencapsulation procedure. ToaaEs, A. I., BOISDRON, C. M., and BENOIT, J. P., y. Microencapsulation, 1996, 13(1), 41–51.
  • Liposome mediated delivery of water soluble antibiotics to the larvae of aquatic animals. TOURAKI, M., RIGAS, P., KASTRITSIS, C., Aquaculture, 1995, 136 (1, 2), 1–10.
  • Effects of free and liposome-encapsulated antibiotics on adherence of Pseudbmonas aerugin-osa to collagen type I. TRAFNY, E. A., STCEPINSKA, M., ANTOS, M., and GRZYBOWSKI, J., Antimicrob. Agents Chemother., 1995, 39 (12), 2645–2649.
  • Cationic liposomal delivery of plasmid to endothelial cells measured by quantitative flow cytometry. TSENG, W., PURVIS, N. B., HASELTON, F. R., and GIORGIO, T. D., Biotechnol. Bioeng., 1996, 50 (5), 548–554.
  • Receptor-mediated gene transfer to hepatic cells using asialofetuin-labeled liposomes. TSUCHIYA, S., and HARA, T., Drug Delivery Syst., 1996, 11(1), 11–20.
  • Counterion effects on colloid stability of cationic vesicles and bilayer-covered polystyrene microspheres. TSURUTA, L. R., and CARMONA, R. A. M., y. Phys. Chem., 1996, 100 (17), 7130–7134. In vitro and in vivo studies on microcapsules and tabletted microcapsules of cephradine. TUNCEL, UNCEL., BERGISADI, N., AKIN, L., OTUK, G., and Kuscu, I., Pharmazie, 1996, 51 (3), 168–171. Preparation and characterization of polylactic acid microspheres containing water-soluble dyes using a novel w/o/w emulsion solvent evaporation method. UCHIDA, T., YOSHIDA, K., and GOTO, S.,Microencapsulation, 1996, 13 (2), 219–228.
  • A column centrifugation method for the reconstitution in liposomes of the mitochondrial FOF1 ATP synthase/ATPase. VAZQUEZ, C. E., TUENA DE G. P. M., and DREYFUS, G., Protein Expression Puri f., 1996, 7 (2), 155–159.
  • Binding and uptake of liposomes containing a poly(ethylene glycol) derivative of cholesterol (stealth liposomes) by the macrophage cell line J774: influence of PEG content and its molecular weight. VERTUT, D. A., ISHIWATA, H., and MIYAJIMA, K., Biochim. Biophys. Acta, 1996, 1278 (1), 19–28.
  • Adverse effects at adjuvant treatment of liver metastases in rat with RSU-1069+ microspheres, or liposomal MTP-PE. WANG, L., Roos, G., and STENRAM, U., Anticancer Res., 1995, 15 (5B), 2077–2080.
  • Hepatic arterial embolization with cisplatin-chitosan-microspheres in dogs. WANG, Y. M., SHI, T. S., Pu, Y. L., ZHU, J. G., and ZHAO, Y. L., Yaoxue Xuebao, 1995, 30 (12), 891–895. Plasmid DNA is protected against ultrasonic cavitation-induced damage when complexed to cationic liposomes. WASAN, E. K., REINTER, D. L., and BALLY, M. B.,Pharm. Sci., 1996,85 (4), 427–433.
  • Differences in lipoprotein concentration and composition modify the plasma distribution of free and liposomal annamycin. WASAN, K. M., and MORTON, R. E., Pharm. Res., 1996, 13 (3), 462–468.
  • Drug delivery system for metastatic mediastinal lymph nodes using ADM-encapsulated liposomes through a bronchofiberscope-an experimental study. WEI, B. R., and TAKAHASHI, H., Tokyo Ika Daigaku Zasshi, 1995, 53 (6), 815–824.
  • Differential effects of methotrexate and liposomally conjugated methotrexate in rat adjuvant. induced arthritis. WILLIAMS, A. S., CAMILLERI, J. P., Amos, N., and WILLIAMS, B. D., Clin. Exp. Immunol., 1995, 102 (3), 560–565.
  • Physiochemical characterization of the nisin-membrane interaction with liposomes derived from Listeria monocytogenes. WINKOWSKI, K., LUDESCHER, R. D., and MONTVILLE, T. J., Appl. Environ. Microbiol., 1995, 62 (2), 323–327.
  • Pyrene-labeled amphiphilic poly(N-isopropylacrylamides) prepared by using a lipophilic radical initiator: synthesis, solution properties in water, and interactions with liposomes. WINNIK, F. M., ADRONOV, A., and KITANO, H., Can. y. Chem, 1995, 73 (11), 2030–2040.
  • Liposome-encapsulated ciprofloxacin for the prevention and treatment of infectious diseases caused by intracellular pathogens. WONG, J. P., CHERWONOGRODZKY, J. W., Di NINNO, V. L., DELA CRUZ, R., and SARAVOLAC, E. G., Drug Targeting Delivery, 1995, 6, 105–120.
  • Effect of the emulsier on the preparation of ethyl cellulose microcapsules by using emulsion nonsolvent addition method. Wu, J. C., CHEN, H., and LIN, Y. T., jiemian Kexue Huizhi, 1995, 18 (4), 223–230.
  • Modeling and analysis of the elution stage of 'perfusion chromatography'. Effects of intraparticle convective velocity and microsphere size on system performance, Xu, Y., and LIAPIS, A. I., J. Chromatogr. A., 1996, 724 (1 + 2), 13–25.
  • Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection. Xu, Y., and SZOKA, F. C. Js., Biochemistry, 1996, 35 (18), 5616–5623.
  • The studies of cationic functional microsphere using soap-free polymerization. Xu, Z., CHENG, S., CHEN, Z., Lu, G., and ZHANG, J., Gongneng Cailiao, 1993, 26 (Suppl.), 580–382.
  • Use of liposomes in scintigraphy. YALCIN, M., OZER, A. Y., and DENKBAS, E., Hacettepe Univ. Eczacilik Fak Derg, 1993, 15 (1), 3–14.
  • Oxidation of alpha-tocopherol during the peroxidation of dilinoleoylphosphatidylcholine in liposomes. YAMAUCHI, R., YAGI, Y. and KATO, K., Biosci. Biotechnol. Biochem., 1996, 60 (4), 616–620.
  • Liposome-mediated gene transfer. YANAGIHARA, 1., KANEDA, Y., INui, K., and OKADA, S., Mol. Cell. Biol. Hum. Dis., 1995,5 (Molecular and Cell Biology of Human Gene Therapeutics), 64–82.
  • Trypanocidal value of liposomal diminazene in experimental Trypanosoma brucei evansi infection in mice. YANG, Y., Ou, Y., RUAN, C., CHENG, Y., and ZHANG, F., Vet Parasitol., 1996, 61(3-4), 349–352.
  • A new embolic material. Superabsorbent polymer (SAP) microsphere and its embolic effects. YAO, j., HORI, S., MINAMITANI, K., HASHIMOTO, T., YOSHINIURA, H., NOMURA, N., ISHIDA, T., FuKUDA, H., TONIODA, K., and NAKAMURA, H., Nippon Igaku Hoshasen Gakkai Zasshi, 1996, 56(1), 19–24.
  • The role of liposomal delivery in cutaneous DNA repair. YAROSH, D., and KLEIN, J., Adv. Drug Delivery Rev., 1996, 18 (3), 325–333.
  • Release profiles of recombinant human tumor necrosis factor from Ca2+ -triggering liposome in vivo. YASUI, K., Fujinick, H., and NAKA:MURA, V., Biol. Pharm. Bull., 1996, 19 (2), 246–251.
  • Handbook of Nonmedical Applications of Liposomes, Volume III: From Design to Micro-reactors. YECHEZKEL, B., and LASIC, D. D. (Ed) (CRC: Boca Raton, Fla.), 1996, 358 pp.
  • Handbook of Nonmedical Applications of Liposomes, Volume II: Models for Biological Phenomena. YECHEZKEL, B., and LASIC, D. D. (Ed) (CRC, Boca Raton, Fla.), 1996, 379 pp.
  • Fluorescence probe studies of the interactions of 1-Alky1-2-pyrrolidones with stratum corneum lipid liposomes. YONETO, K., Li, S. K., HIGUCHI, W. 1., JISKOOT, W. and HERRON, J. N., I. Pharm. Sci., 1996, 85 (5), 511–517.
  • Microencapsulation of food condiments. YONG, G., Zhongguo Tiaoweipin, 1995, (11), 2-3. Photolysis of retinal in liposomes and its protection with tocopherol and oxybenzone. YOUNG, A. M., and OREGORIADIS, G., Photochem. Photobiol, 1996, 63 (3), 344–352.
  • Photodynamic therapy of pigmented choroidal melanomas using a liposomal preparation of benzoporphyrin derivative. YOUNG, L. H. Y., HOWARD, M. A., Hu, L. K., KINI, R. Y., and ORAGOUDAS, E. S., Arch. Ophthalmol. (Chicago), 1996, 114 (2), 186–192.
  • Triamcinolone permeation from different liposome formulations through rat skin in vitro. Yu, H. Y., and LIAO, H. M., Int. y. Pharm., 1996, 127(1), 1–7.
  • The measurement of phosphorus release rate for medical 32P labeled glass microspheres. Zhai, S., Wang, J., and WANG, H., Tongtveisu, 1995, 8 (3), 163–166.
  • Study on the lung targeting gelatin microspheres of streptomycin sulfate. ZHANG, Z., LU, B., SHI", G., Xis, H., VI, Q., HE, Y., and WANG, j., Huaxi Yike Daxue Xuebao,1995, 26(2), 167–171.
  • Gamma-irradiation of non-frozen, frozen, and freeze-dried liposomes. ZUIDAM, N. J., LEE, S. S., and CRONIMELIN, D. J., Pharm. Res., 1995, 12(11), 1761–1768.
  • Gamma-irradiation of liposomes composed of saturated phospholipids. Effect of bilayer composition, size, concentration and absorbed dose on chemical degradation and physical destabilization of liposomes. ZUIDAM, N. J., VERstxis, C., YERNOOY, E. A. A. M., and CRONIMELIN, D. J. A., Biochim. Biophys. Acta, 1996, 1280 (1), 135–148.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.